JNJ vs PL · P/E 17, rev $49.37B vs rev $307.7M
Johnson & Johnson (JNJ) versus Planet Labs PBC (PL) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Planet Labs PBC (PL) is a aerospace & defense company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported PL revenue for 2026-01-31 was $307.7M. Net income was -$246.9M. Revenue was up 25.9% from 2025-01-31 to 2026-01-31. PL currently screens at market cap $2.08B.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. PL currently screens at market cap $2.08B.
Not investment advice. Open the JNJ and PL stock pages for the full models.
Not investment advice.